Pre-existing frontal lobe dysfunction signs as predictors of subsequent neurotoxicity in CAR T cell therapy: insights from a case series-Reference-Cited by-同舟云学术

Pre-existing frontal lobe dysfunction signs as predictors of subsequent neurotoxicity in CAR T cell therapy: insights from a case series

Published:2023-05-10 Issue:9 Volume:44 Page:3291-3297
ISSN:1590-1874
Container-title:Neurological Sciences
language:en
Short-container-title:Neurol Sci

Author:

Fontanelli Lorenzo,Pizzanelli Chiara^ORCID,Milano Chiara,Cassano Cassano Raffaella,Galimberti Sara,Rossini Maria Ida,Santo Ignazio,Turco Francesco,Bonanni Enrica,Siciliano Gabriele,Orciuolo Enrico,Baldacci Filippo

Publisher

Springer Science and Business Media LLC

Subject

Psychiatry and Mental health,Neurology (clinical),Dermatology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s10072-023-06841-6.pdf

Reference25 articles.

1. Ma S, Li X, Wang X et al (2019) Current progress in CAR-T cell therapy for solid tumors. Int J Biol Sci 15:2548–2560

2. Rubin DB, Danish HH, Ali AB et al (2019) Neurological toxicities associated with chimeric antigen receptor T-cell therapy. Brain 142:1334–1348

3. Lee DW, Santomasso BD, Locke FL et al (2019) ASTCT consensus grading for cytokine release syndrome and neurologic toxicity associated with immune effector cells. Biol Blood Marrow Transplant 25:625–638

4. Neelapu SS, Tummala S, Kebriaei P et al (2018) Chimeric antigen receptor T-cell therapy-assessment and management of toxicities. Nat Rev Clin Oncol 15:47–62

5. Grant SJ, Grimshaw AA, Silberstein J et al (2022) Clinical presentation, risk factors, and outcomes of immune effector cell-associated neurotoxicity syndrome following chimeric antigen receptor T cell therapy: a systematic review. Transplant Cell Ther 28:294–302

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The new era of immunological treatment, last updated and future consideration of CAR T cell-based drugs;Pharmacological Research;2024-05

2. Axicabtagene-ciloleucel/brexucabtagene-autoleucel/tisagenlecleucel;Reactions Weekly;2023-10-21